Condition (MeSH)
Cheilitis
ClinicalTrials.gov lists 2 trials for Cheilitis or a narrower condition beneath it. Gaziosmanpasa Research and Education Hospital has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
4 sections measured, none recorded · 1 not measured yet · 1 not computed
2 of the 2 trials are tagged with Cheilitis itself; the rest are tagged with a narrower condition beneath it.
When did Cheilitis trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2021 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cheilitis trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Not applicable | 2 |
How many Cheilitis trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cheilitis trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Gaziosmanpasa Research and Education Hospital | 1 |
Which publications cover Cheilitis? (35)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Efficacy and safety of a 0.05 % nanoencapsulated imiquimod hydrogel for the treatment of actinic cheilitis: Drug release analysis and clinical study. | Nanomedicine : nanotechnology, biology, and medicine | 2024 | Yes |
| Angular cheilitis of COVID-19 patients: A case-series and literature review. | Oral diseases | 2022 | Yes |
| Lip mesotherapy with dexpanthenol in the treatment of isotretinoin-induced cheilitis. | Journal of cosmetic dermatology | 2022 | Yes |
| Hyaluronic acid dermal fillers in the management of recurrent angular cheilitis: A case report. | Gerodontology | 2018 | Yes |
| Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. | Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology | 2018 | Yes |
Showing 5 of 35 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.